TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
KRRO

Korro Bio, Inc.

Healthcare · Biotechnology

10.00$ -15.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement KRRO
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0%
58.1% 4.3% 27.3% 157.0% 67.0%
41.9% 95.7% 72.7% 100.0% 33.0%
63.3% 99.1% 169.2% 2,802.1% 1,025.9%
83.1% 1,345.0% 440.5%
113.3% 170.2% 252.3% 4,147.1% 1,399.5%
-71.4% -74.5% -252.3% -4,047.1% -1,366.4%
5.4%
-64.8% -71.6% -156.1% -3,674.2% -1,824.5%
0.1% 0.0% 6.2% 10.0%
-64.8% -71.7% -156.1% -3,680.4% -1,834.5%
-62.0% -67.3% -241.0% -3,890.1% -1,299.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?